2-Pyridinecarboxamide, N-[1-[2-[(cyclopropylsulfonyl)amino]-4-thiazolyl]cyclopropyl]-5-(6-ethoxy-2-pyrazinyl)-

CTPS1-IN-1 (compound R80) is a CTPS1 inhibitor. CTPS1-IN-1 has the potential to research cancer (such as promoting vascular injury or surgical recovery) and immune system diseases (such as rejection of transplanted cells and tissues, transplant-related diseases or disorders, allergies, and autoimmune diseases)[1].

[1] Andrew Novak, et al. Preparation of substituted sulfonamidothiazoles as CTRS1 inhibitors. Patent WO2019106146A1.